Indian Government decides to give the license to Indian generic drug maker whereas their patent's remaining.
Of course, Bayer said the statement against this decision.
They indicated their disappointment.
India allows copy of cancer drug
India allows copy of cancer drug - BBC News
An assortment of pills Natco Pharma's version of Nexavar will be massively cheaper for patients
Continue reading the main story
Related Stories
India's government has permitted a local company to manufacture a generic copy of a patented cancer drug to make it affordable to Indian patients.
It allowed Natco Pharma to make and sell Nexavar, which will be available to patients for 8,800 rupees ($176; £112) for a 120-tablet pack.
Bayer, which holds the patent, charges 280,000 rupees for 120 tablets.
India invoked a trade rule allowing generic production of a patented drug which was unaffordable.
Recently, the cost of innovative drugs is increasing more and more.
In the Developing countries, almost of all people are poor yet.
When the patients become disease, they can't take a good enough treatment.
Therefore, Indian Government had to decide it to help their own people.
In the future, the Developing countries have the opportunity to become a big market because the population explosion will happen only in these countries.
The BigPharma have to rethink the strategy to get the share at these countries and to avoid these Government's decision.
